ROSEN, THE FIRST FILING FIRM, Encourages Edison International Investors to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Firm - EIX — Neutral
EIX Accesswire — April 04, 2025NEW YORK CITY, NY / ACCESS Newswire / April 4, 2025 / WHY: New York, N.Y., April 4, 2025.
Shareholders that Lost Money on Geron Corporation (GERN) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More — Neutral
GERN Accesswire — April 04, 2025NEW YORK, NY / ACCESS Newswire / April 4, 2025 / If you suffered a loss on your Geron Corporation (NASDAQ:GERN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/geron-corporation-lawsuit-submission-form?prid=141100&wire=1 or contact Joseph E. Levi, Esq.
April 14, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against MRK — Neutral
MRK Accesswire — April 04, 2025NEW YORK, NY / ACCESS Newswire / April 4, 2025 / If you suffered a loss on your Merck & Co., Inc. (NYSE:MRK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/merck-co-inc-lawsuit-submission-form?prid=141096&wire=1 or contact Joseph E. Levi, Esq.
Levi & Korsinsky Notifies Shareholders of Elastic N.V. (ESTC) of a Class Action Lawsuit and an Upcoming Deadline — Neutral
ESTC Accesswire — April 04, 2025NEW YORK, NY / ACCESS Newswire / April 4, 2025 / If you suffered a loss on your Elastic N.V. (NYSE:ESTC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/elastic-n-v-lawsuit-submission-form?prid=141099&wire=1 or contact Joseph E.
Shares of Nvidia (NVDA -6.54%) are plummeting on Thursday. The artificial intelligence (AI) chip giant's stock lost 7.8% as of 1:30 p.m.
Affirm heads for second-worst week on record on tariff worries, Klarna delayed IPO — Negative
AFRM KLAR CNBC — April 04, 2025Affirm shares plummeted about 30% in two days following President Trump's tariff announcements, on concerns that consumers will pull back on spending. Rival Klarna delayed its long-anticipated IPO, as did ticket marketplace StubHub.
Acuity Q2 Earnings Beat Estimates, Sales Miss, Stock Down — Positive
AYI Zacks Investment Research — April 04, 2025AYI's fiscal second-quarter results reflect solid Intelligent Spaces contributions, better cost management and operational efficiency.
Why Tesla Stock Is Crashing Today -- It's Not Just Trump's Tariffs — Negative
TSLA The Motley Fool — April 04, 2025Shares of Tesla (TSLA -9.25%) are sliding on Friday. The electric vehicle maker's stock lost 10% as of 1:30 p.m.
Reciprocal tariffs announced by President Trump have caused significant market shifts, with the iShares 20+ Year Treasury Bond ETF breaking to a new 2025 high. Long-term yields are influenced by inflation expectations and lower growth expectations; currently, growth concerns dominate. Tariffs could generate $600B annually for the government, reducing UST issuance and positively impacting TLT.
Seeking to punish cheaters, Saudi Arabia pushes OPEC+ to open oil taps — Neutral
BNO DBO GUSH IEO OIH OIL PXJ UCO USO XOP Reuters — April 04, 2025Saudi Arabia's anger at Kazakhstan and other over producing nations was the key driver behind a shock decision by the OPEC+ oil group to open taps on Thursday and might not be reversed even if oil prices fall further, three OPEC+ sources told Reuters.
Strength Seen in Centene (CNC): Can Its 5.9% Jump Turn into More Strength? — Positive
CNC Zacks Investment Research — April 04, 2025Centene (CNC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Gorilla Technology Reports 2024 Earnings: Pipeline Getting Bigger? — Positive
GRRR Zacks Investment Research — April 04, 2025New contracts, global expansion and disciplined execution benefit GRRR's results.
Rocket Lab USA, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before April 28, 2025 to Discuss Your Rights - RKLB — Neutral
RKLB Accesswire — April 04, 2025NEW YORK, NY / ACCESS Newswire / April 4, 2025 / If you suffered a loss on your Rocket Lab USA, Inc. (NASDAQ:RKLB) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/rocket-lab-usa-inc-lawsuit-submission-form?prid=141097&wire=1 or contact Joseph E. Levi, Esq.
ROSEN, A RANKED AND LEADING FIRM, Encourages Pony AI Inc. Investors to Inquire About Securities Class Action - PONY — Neutral
PONY Accesswire — April 04, 2025NEW YORK CITY, NY / ACCESS Newswire / April 4, 2025 / WHY: New York, N.Y., April 4, 2025.
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Ready Capital Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - RC — Neutral
RC Accesswire — April 04, 2025NEW YORK CITY, NY / ACCESS Newswire / April 4, 2025 / WHY: New York, N.Y., April 4, 2025.
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into Guess Inc — Neutral
GES Accesswire — April 04, 2025NEW YORK, NY / ACCESS Newswire / April 4, 2025 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own Guess Inc. ("GES" or the "Company") (NYSE:GES) stock purchased prior to March 16, 2025. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the proposed purchase of Guess, Inc. (NYSE: GES) by WHP Global, whether the proposed buyout price fairly compensates investors, and whether all material facts have been properly disclosed to stockholders.
Sky Harbour Group: A Contrarian Buy Opportunity
SRDX Stock Dips Despite the Launch of Pounce XL Thrombectomy System — Neutral
SRDX Zacks Investment Research — April 04, 2025Surmodics launches the Pounce XL Thrombectomy System, aiming to enhance clot removal efficiency, improve patient outcomes, and expand its portfolio of vascular interventions.
